LAKE OSWEGO, Ore., Aug. 23, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, President and CEO, will present a corporate overview at the 2012 Southern California Investor Conference. The presentation will take place on Thursday, August 30, 2012 at 2:00 p.m. PDT at the Marriott Hotel in Newport Beach, CA.
The presentation will be webcast and available on the Company's website at http://investors.galenabiopharma.com/events.cfm .
About Galena BiopharmaGalena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com . The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647
CONTACT: Madeline Hatton Toll free: +1 (855) 855-GALE (4253), ext. 109 email@example.com or Remy Bernarda IR Sense, LLC +1 (415) 203-6386 firstname.lastname@example.org